Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: QS stock price vs PHG: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at PHG's multiple
Needs Revenue / share.
Implied fair value · at QS's multiple
Needs QS P/S.
Metric by metric
Snapshot Sep 4, 4:00 PM ET
Where each company leads, and how wide the gap is.
Higher is better
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: QS FY 2025 (ended Dec 31, 2025) · PHG FY 2025 (ended Dec 31, 2025).
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 96% equity / 4% debt · EV / EBITDA 0.99x
Capital structure 61% equity / 39% debt · EV / Revenue 1.94x · EV / EBITDA 29.13x
PHG carries the larger enterprise value at $40.12B against -$425.39M; QS trades on the lower EV / EBITDA multiple (0.99x vs 29.13x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
QUANTUMSCAPE CORPORATION · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
KONINKLIJKE PHILIPS NV · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
0.02x
—
Net debt / EBITDA
Leverage against operating earnings
2.21x
11.03x
Cash and equivalents
Liquid reserves on the balance sheet
$970.81M
$2.79B
Total debt
Interest-bearing obligations outstanding
$22.36M
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Microvast Holdings, Inc.
QS vs MVST
Fluence Energy, Inc.
QS vs FLNC
Enovix Corp
QS vs ENVX
APPLIED MATERIALS INC /DE
QS vs AMAT
GE HealthCare Technologies Inc.
QS vs GEHC
HOLOGIC INC
QS vs HOLX
BOSTON SCIENTIFIC CORP
QS vs BSX
INTUITIVE SURGICAL INC
QS vs ISRG
ZIMMER BIOMET HOLDINGS, INC.
QS vs ZBH
$15.86B
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
